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Biocatalytic Conversion of Cyclic Ketones Bearing a-Quaternary
Stereocenters into Lactones in an Enantioselective Radical Approach
to Medium-Sized Carbocycles
Charlotte Morrill, Chantel Jensen, Xavier Just-Baringo, GideonGrogan, Nicholas J. Turner,* and
David J. Procter*
Abstract: Cyclic ketones bearing a-quaternary stereocenters
underwent efficient kinetic resolution using cyclohexanone
monooxygenase (CHMO) from Acinetobacter calcoaceticus.
Lactones possessing tetrasubstituted stereocenters were
obtained with high enantioselectivity (up to > 99% ee) and
complete chemoselectivity. Preparative-scale biotransforma-
tions were exploited in conjunction with a SmI2-mediated
cyclization process to access complex, enantiomerically
enriched cycloheptan- and cycloctan-1,4-diols. In a parallel
approach to structurally distinct products, enantiomerically
enriched ketones from the resolution with an a-quaternary
stereocenter were used in a SmI2-mediated cyclization process
to give cyclobutanol products (up to > 99% ee).
The Baeyer–Villiger (BV) reaction[1] transforms ketones into
esters or lactones with predictable regioselectivity and is
therefore a valuable tool for synthesis. Metal-based catalysts[2]
and organocatalysts[3] have been developed for catalytic
enantioselective variants of the BV reaction; however, high
enantioselectivity is generally limited to the transformation of
activated cyclobutanone substrates, in which the release of
ring strain drives the BV reaction.[4] Baeyer–Villiger mono-
oxygenases (BVMOs) offer an attractive alternative to the
use of chemical reagents for enantioselective BV reactions.
These flavin-dependent enzymes exploit atmospheric oxygen
and catalyze the transformation via an enzyme-bound
(hydro)peroxyflavin intermediate.[5] The use of BVMOs
promises distinct advantages in terms of enantioselectivity,
substrate scope, and chemoselectivity not possible using
chemical reagents.[6]
BV transformations of a,a-dialkyl cyclic ketones have the
potential to deliver enantiomerically enriched lactones with
tetrasubstituted stereocenters and cyclic ketones bearing a-
quaternary centers. Such products possess hard-to-build
stereocenters[7] and are high-value chiral building blocks for
synthesis.[8] To our knowledge, there are no reports of the
enantioselective BV reaction of a,a-dialkyl cyclic ketones
using chemical reagents.[2b,g] Furthermore, the ability of
BVMOs to catalyze the kinetic resolution of a,a-dialkyl
cyclic ketones was, until now, unexplored (Scheme 1A).[9] The
synthetic reach of biocatalytic reactions is greatly extended
when enzymatic processes are integrated into synthetic
sequences involving chemical catalysts and reagents.[10]
Herein, we describe a highly enantioselective and chemo-
selective, biocatalytic Baeyer–Villiger approach to unsatu-
rated lactones II bearing tetrasubstituted stereocenters that
proceeds by the kinetic resolution of cyclic ketones I bearing
a-quaternary stereocenters. Crucially, lactones II are not
readily accessible in enantiomerically enriched form by state-
of-the-art chemical methods.[11] Lactones II are excellent
Scheme 1. A. BVMOs in the kinetic resolution of cyclic ketones: lack of
precedent for the resolution of substrates bearing a-quaternary stereo-
centers. B. An approach to complex, medium-sized cycloalkanols that
exploits the synergy between a biocatalytic and a chemical process.
C. The biological importance of molecules containing cycloheptanol
and cyclooctanol motifs.
[*] C. Morrill, Dr. C. Jensen, Dr. X. Just-Baringo, Prof. N. J. Turner,
Prof. D. J. Procter
School of Chemistry, University of Manchester
Manchester, M13 9PL (UK)
E-mail: Nicholas.Turner@manchester.ac.uk
david.j.procter@manchester.ac.uk
Prof. G. Grogan
Department of Chemistry, University of York
Heslington, York, YO10 5DD (UK)
Supporting information and the ORCID identification number(s) for
the author(s) of this article can be found under:
https://doi.org/10.1002/anie.201800121.
T 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co.
KGaA. This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly
cited.
Angewandte
ChemieCommunications
3692 T 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2018, 57, 3692 –3696
substrates for SmI2–H2O-mediated
[12] cyclization reactions,
which complete an enantioselective biocatalytic–chemical
approach to important and complex cycloheptan- and cyclo-
ctan-1,4-diols III (Scheme 1B): structural motifs that are
notoriously hard to prepare and that are prevalent in
biologically relevant targets (Scheme 1B,C).[13]
The biocatalytic kinetic resolution was explored using the
purified CHMOActineto enzyme from Acinetobacter calcoaceti-
cus (NCIMB 9871). A glucose/glucose dehydrogenase
(GDH) recycling system was employed for catalytic regener-
ation of the NADPH cofactor,[14] and the feasibility of the
biotransformation was initially assessed on an analytical scale
using ketone 1a (R1=Me, R2=H). Pleasingly, despite the
lack of precedent for the resolution of substrates bearing a-
quaternary centers, lactone 2a was efficiently formed with
> 99% ee at a conversion of 50% (Table 1). A control
reaction, in which 1a was exposed to the reaction conditions
in the absence of CHMO, resulted in no conversion into the
product. To assess the scope of the transformation, we
prepared a range of lactones bearing various aryl groups on
the alkene unit in one straightforward step from 1a (see the
Supporting Information). Despite the presence of the bulky
aryl substituents and the a-quaternary center, we were
pleased to observe unprecedented tolerance on the part of
CHMO, and all six-membered ketones 1 were transformed
into seven-membered lactones 2 with very high enantioselec-
tivity (selectivity factors, E> 200; Table 1).
Selective formation of the R enantiomer of the lactone
products was confirmed for 2a–c and inferred for the
remainder.[15] For substrates bearing a methyl substituent at
the a-quaternary center, conversions up to 50% (the max-
imum theoretical value for an ideal kinetic resolution) were
observed. In stark contrast to chemical oxidation of 1b to 2b,
no side products resulting from competing oxidation of the
alkene in the starting material and product were observed.[16]
Thus, the biocatalytic process exhibited complete chemo-
selectivity. Substitution was tolerated at all positions on the
aromatic ring, with halogen, methyl, and trifluoromethyl
substituents all accepted by the enzyme active site. Substrates
1d and 1e, bearing bulky 2-naphthyl and 3-bromophenyl
substituents, were transformed less efficiently by the enzyme,
and lower conversion was observed; however, enantioselec-
tivity remained high. Variation of the pH value of the reaction
mixture and the use of an alternative biocatalyst, cyclo-
dodecanone monooxygenase (CDMORhodo) from Rhodococ-
cus, did not lead to improved conversion.[17] Ketone 1 i, in
which the R1 group was an ethyl rather than a methyl
substituent, was transformed inefficiently, although a small
amount of product was formed with high enantiocontrol.
Following assessment of the process on an analytical scale,
transformations were performed on a preparative scale
(0.2 mmol; formation of 2a–c, 2 f). Facile separation of the
product from the ketone afforded pure samples of the
enantiomerically enriched lactone products. For substrates
1a–c, 1 f, high-value ketones bearing a-quaternary stereocen-
ters were obtained in high enantiomeric purity after the
kinetic resolution (see below).
We also explored the scope of the biocatalytic kinetic
resolution with respect to the formation of six-membered
lactones. A range of five-membered-ring ketones 3 was
prepared and subjected to the CHMO-catalyzed transforma-
tion (Table 2). Although the biotransformations were typi-
cally less efficient than those involving six-membered cyclic
ketones, in some cases lactone products 4 were formed with
selectivity factors (E= 17–59) indicative of useful synthetic
procedures. For example, cyclopentanones 3c and 3h under-
went significant conversion, and lactones 4c and 4h were
obtained in 96 and 88% ee, respectively. Five-membered
cyclic ketones 3d, 3e, and 3g containing larger aromatic
substituents showed very little or no conversion into lactone
products (Table 2). Selective formation of the R enantiomer
of the lactone products was confirmed for 4a–c and inferred
for the remainder.[15] Analogous ketone substrates with
a seven-membered ring were incompatible with the biocat-
alytic process.[15]
Berghuis and co-workers have previously determined the
structure of CHMORhodo, a homologue of CHMOActineto, in its
“tight” conformation in complex with e-caprolactone, the
product of BV oxidation of cyclohexanone (PDB code
4RG3),[18] and suggest that the stereoselectivity of the
reaction is determined in this conformation of the enzyme.
CHMOAcineto used in this study shares 55% amino acid
sequence identity with CHMORhodo, and the majority of
residues within the active site are conserved, thus allowing the
Table 1: Biotransformations of six-membered cyclic ketones bearing a-
quaternary stereocenters catalyzed by CHMOAcineto.
Reaction conditions for analytical-scale biotransformations: Ketone
(1 mgmL@1), CHMO (0.25 mgmL@1), NADPH (0.7 mm), GDH
(0.25 mgmL@1), glucose (5.5 mm), Tris/HCl buffer (100 mm). [a] Con-
version determined by GC or 1H NMR analysis of the crude reaction
mixture. [b] The yield of the isolated product is shown in brackets for
a preparative-scale transformation. For a detailed description of the
procedure for the preparative-scale biotransformations, see the Sup-
porting Information; ee values were determined by chiral-stationary-
phase GC or HPLC analysis.
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construction of a model of CHMOAcineto such as that pre-
viously presented by Reetz and co-workers.[19] The model was
used as the input for an in silico docking experiment with the
enantiomers of lactone product 2a. Figure 1 shows the
R enantiomer of 2a, the preferred product of the reaction,
beneath the FAD coenzyme with its alkenyl substituent
accommodated in the hydrophobic pocket formed by the side
chains of L435, F505, and F432, the latter having been shown
through mutation to have a profound influence on the
enantioselectivity of CHMOAcineto-catalyzed reactions.
[20] The
pose would also permit the accommodation of larger side
chains, such as those in the R lactone products 2b and 2c. The
role of this region in the accommodation of bulky side chains,
such as that of 2-phenyl cyclohexanone, has previously been
demonstrated.[19] Interestingly, the 2a lactone carbonyl group
in the top pose superimposes well with the equivalent atom in
the 4RG3–e-caprolactone complex, at a distance of 3.3c
from the ribose 1-hydroxy group and 2.7c from the side
chain of R327, which is thought to stabilize the oxyanion in
the Criegee intermediate in the same position.
Radical approaches to challenging medium-sized carbo-
cycles are highly prized.[22] In particular, radical cyclization
reactions to give cyclooctanes are scarce and are mostly
limited to 8-endo cyclization modes. We previously reported
a 5-exo-trig radical cyclization approach that converts unsa-
turated six- and seven-membered lactones into complex
seven- and eight-membered cycloalkanols; however, until
now the process could only deliver racemic products, as
enantiomerically enriched starting lactones could not readily
be prepared.[12g,j] Achieving enantiomeric control in SmI2-
mediated reactions of achiral or racemic substrates is
challenging,[23] and the use of enantiomerically enriched
substrates in diastereoselective processes is a more general
approach to access enantiomerically enriched products.
The enantiomerically enriched lactones 2/4 formed by the
biocatalytic Baeyer–Villiger reaction were excellent sub-
strates for diastereoselective radical cyclization reactions
mediated by SmI2–H2O. Upon treatment with SmI2–H2O,
lactones 2/4 underwent efficient 5-exo-trig radical cyclization
to give seven- and eight-membered cycloalkanols 5 in good
yield. Oxidation of the crude product mixtures simplified the
diastereoisomeric mixtures and afforded the cycloalkanoid
products 6 with up to 6:1 dr. The reaction proceeded with no
loss of enantiomeric enrichment, and important cyclooctanol
motifs were obtained with > 99% ee.
The radical cyclization proceeds by electron transfer from
SmII to the carbonyl group of the enantiomerically enriched
lactones formed by the biocatalytic BV reaction. The
resultant radical anions IV (see Table 3) undergo intra-
molecular addition to the alkene acceptor to give hemiketal
intermediates that are reduced in situ by SmI2–H2O to give
enantiomerically enriched seven- and eight-membered cyclo-
alkanol products 5 in good yield.
The biocatalytic transformation of a,a-dialkyl cyclic
ketones delivers not only enantiomerically enriched lactones
2 but also enantiomerically enriched cyclic ketones 1 recov-
ered from the kinetic resolution (Scheme 2). For example, the
biocatalytic transformation to give lactone 2b (43% isolated
yield, > 99% ee) also gave ketone 1b (39% isolated yield,
> 99% ee) bearing an a-quaternary stereocenter. Pleasingly,
SmI2-mediated radical cyclization of 2b gave enantiomeri-
cally pure cyclobutanol 7a with complete diastereocontrol in
84% yield.[24] Cyclobutanols 7b and 7c could similarly be
Table 2: Biotransformations of five-membered cyclic ketones bearing a-
quaternary stereocenters catalyzed by CHMOAcineto.
Reaction conditions for analytical-scale biotransformations: Ketone
(1 mgmL@1), CHMO (0.25 mgmL@1), NADPH (0.7 mm), GDH
(0.25 mgmL@1), glucose (5.5 mm), Tris/HCl buffer (100 mm). [a] Con-
version determined by GC or 1H NMR analysis of the crude reaction
mixture. [b] The yield of the isolated product is shown in brackets for
a preparative-scale transformation. For a detailed description of the
procedure for the preparative-scale biotransformations, see the Sup-
porting Information; ee values were determined by chiral-stationary-
phase GC or HPLC analysis.
Figure 1. Model of CHMOAcineto in complex with lactone product (R)-2a
created using Autodock-Vina.[21] Backbone and side chains of the
enzyme are shown in light blue; carbon atoms of FAD, NADP+, and
2a are shown in gray, green, and yellow, respectively. Selected
interactions are indicated by black dashed lines with distance in
angstroms.
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obtained from resolved ketones bearing a-quaternary stereo-
centers, 1 f and 3b. Thus, biocatalytic kinetic resolution of
racemic ketones 1 and 3, when used in combination with
metal-mediated radical cyclization reactions, allows divergent
access to important carbocyclic products with very different
molecular architectures in enantiomerically enriched form.
In summary, racemic cyclic ketones bearing a-quaternary
stereocenters underwent efficient kinetic resolution using
cyclohexanone monooxygenase (CHMO) fromAcinetobacter
calcoaceticus. The new biocatalytic process has been used in
combination with new radical cyclization reactions to access
important enantiomerically enriched carbocyclic scaffolds. In
particular, lactones possessing tetrasubstituted stereocenters
were obtained with high enantioselectivity (up to > 99% ee)
and were exploited in SmI2-mediated cyclization processes to
access complex, enantiomerically enriched cycloheptan- and
cycloctan-1,4-diols. In a divergent approach to structurally
distinct molecular architectures, enantiomerically enriched
cyclic ketones from the resolution, bearing an a-quaternary
stereocenter, were used in a SmI2-mediated cyclization
process to give cyclobutanol products (up to > 99% ee).
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